Chemically known as hexanedioic acid, adipic acid is a dicarboxylic organic acid produced during omega‑oxidation of medium‑ and long‑chain fatty acids. In human metabolism omega‑oxidation occurs in microsomal pathways and generates dicarboxylic acids that are further processed or excreted in urine. Adipic acid also has an industrial presence (used in some plastics and food processes), so urinary levels can reflect both endogenous metabolic activity and external exposure. In clinical organic acid testing, adipic acid serves as a marker of shifts in fatty‑acid handling and of increased reliance on alternative oxidation pathways when standard mitochondrial beta‑oxidation is limited or overwhelmed.

Elevated adipic acid may indicate increased omega‑oxidation, an alternative fatty‑acid breakdown route that becomes more active with high fatty‑acid flux, impaired mitochondrial beta‑oxidation capacity, limited carnitine‑dependent transport, or certain environmental/dietary exposures. Because many conditions and timing factors can raise adipic acid, isolated elevation requires correlation with other markers such as additional dicarboxylic acids, acylcarnitines, ketone bodies, and lactate. Low or normal adipic acid typically reflects efficient mitochondrial beta‑oxidation, low circulating fatty‑acid substrate (for example after fasting or low‑fat intake), or simply a lack of significant omega‑oxidation activity. Low values alone do not exclude metabolic stress elsewhere; interpretation is most informative within the full Cellular Zoomer profile and clinical context.

Adipic acid is included in the Cellular Zoomer to flag shifts to omega‑oxidation and altered fatty‑acid handling—signals that mitochondrial function or detox pathways may be strained. Combined with acylcarnitines, other organic acids, and oxidative damage markers, adipic acid helps providers map specific patterns of metabolic stress and personalize follow‑up testing and monitoring.